Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

A glucose Monitor's second chance: can it tame type 1 diabetes in High-Risk teens?

NCT ID NCT07742306

Disease control Sponsor: Life for a Child Program, Diabetes Australia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 03, 2026 · Last updated Aug 14, 2026 · Updated 3 times

Summary

This pilot study tests whether intermittent use of a continuous glucose monitor (CGM), along with regular medical visits, diabetes education, and psychological support, can improve blood sugar control in children and adolescents with high-risk type 1 diabetes in the Dominican Republic. Forty participants aged 10 to 19 will use the Dexcom G7 CGM during two short monitoring periods, then return to usual finger-stick checks. The study will track changes in HbA1c, time in range, glucose variability, and diabetes-related distress to see if this combined approach helps.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Intermittent use of the Dexcom G7 continuous glucose monitor, combined with pediatric endocrinology follow-up, diabetes education, and psychological support
What this could lead to
If effective, this approach could offer a practical, resource-sensitive way to improve glucose control and reduce diabetes distress in high-risk youth, potentially informing broader care in similar settings.
What could go wrong
This is a small pilot study with only 40 participants, so results may not apply widely. The intermittent CGM use may not be enough to sustain improvements, and the added visits and support could be hard to maintain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Individuals diagnosed with T1D aged between 10-19 years of age with an HbA1c \>9.0% that are managed at two pediatric endocrinology health-centers in the Dominican Republic. These include the Pediatric Hospital Regional Universitario Dr. Arturo Grullon en Santiago de Caballeros (STI) and Pediatric Hospital Robert Reid Cabral with assistance provided by the foundation Aprendiendo a Vivir in the city of Santo Domingo (SD).

Ages

10 to 19 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * HbA1c \>9.0% * Age range: 10-19 years * Disposition and availability for patients and families to attend scheduled provider meetings, as well as general diabetic educational and psychological support meetings throughout the whole study. Namely, meeting every 2 weeks for the first 3 months and then every 4 weeks until completion of study for next 12 months. * Willingness and ability to provide signed voluntary consent form. Date and signature is requested however based on literacy levels a patient can provide consent verbally as long as there is a witness who is 18 years or older and demonstration of acknowledgement of information provided. Exclusion Criteria: * Diagnosis of T1D within the past 12 months * Previous or current use of CGM like FreeStyle Libre 2, Dexcom (G6, G7), or similar devices from other companies not mentioned * Current use of continuous insulin pump in combination with CGM use at present or prior to study * Residence location with greater than 3 hours of travel time distance from each health center in setting of cost and feasibility for families to travel on frequent necessary basis * Current steroid therapy orally or intravenously. * Medical comorbidities including chronic renal disease, hemoglobinopathies, leukemia, hematologic or oncologic conditions that can affect glycemia * Pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 1 diabetes (T1D) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Type 1 diabetes (T1D)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Fundación Aprendiendo a Vivir

    RECRUITING

    Santo Domingo, Dominican Republic

  • Hospital Infantil Regional Universitario Dr. Arturo Grullón

    RECRUITING

    Santiago de los Caballeros, Dominican Republic

  • Hospital Infantil Robert Reid Cabral

    RECRUITING

    Santo Domingo, Dominican Republic

More trials for these conditions

Other studies related to the condition(s) this trial covers.